Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.

Pile of papers with bright paperclips © Shutterstock

The living reviews will summarise literature around one topic and are a response to the speed and volume of COVID-19 immunology research published during the pandemic.

On behalf of the Oxford-Cardiff COVID-19 Literature Consortium, Dr Ewoud Compeer, University of Oxford points out the idea behind this new publishing format: "The field of COVID-19 immunology was seeing new developments and new hypotheses appearing at an extreme pace online in the form of pre-prints. This speed of publishing made literature reviews outdated even before a journal published them. Our 'living reviews' will stay "live" for a designated period, being updated as change happens."

The journal publishes peer reviewed scientific articles, and the annotation enables rapid communication of updated information, but the version of record does not change so provides a history of the scientific developments.

Professor Awen Gallimore, Cardiff University finds similar advantages to the 'live' format of reviews: "Because new information emerges day by day, when you publish something on Monday by the following Friday it may already be out of date. Our living reviews enable as-you-go updates and should represent a useful step towards supporting scientists address the big and trending research questions."

The COVID-19 Literature initiative began with a team of around 100 post-doctoral researchers, DPhil students, and faculty members from the Medical Sciences Division at the University of Oxford reading, reviewing and summarising the latest COVID-19 research from all round the world in order to support frontline researchers.

At Cardiff, the School of Medicine-wide Journal Club, also comprising PhD students, post-docs and ECRs had started a similar initiative. Oxford and Cardiff joined forces to pool expertise around a wider range of disciplines and ensure those on the frontline were up to date with the latest developments in the field.

The living reviews add to a growing body of material from the Oxford-Cardiff COVID-19 Literature Consortium that is available through their website, and popular science blog, and could become a new benchmark for reviewing research in the future.

"We are pleased to be able to support the research community with this new series of Living Reviews from the Oxford-Cardiff COVID-19 Literature Consortium. We're excited to be able to offer this new open annotation functionality to our authors in Oxford Open Immunology and hope that this innovative new format will generate a useful and up to date resource for readers," said Rhiannon Meaden, Senior Publisher at OUP.

"The reviews were like a paint-by-numbers, we knew there were bits missing and new colours were coming in week by week, but it would be years before we got the whole picture," said Luke Davies from Cardiff University, one of the authors of the first published review. "A living review allows us to carefully add to the picture over time, while still delivering an up-to-date snapshot of the field that can aid ongoing research."

The first living reviews to be published are: Viral entry, sensing and evasion, and Dysregulated inflammation drives immunopathology.

 

 

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.